Europace Advance Access originally published online on May 23, 2007
Europace 2007 9(7):531-532; doi:10.1093/europace/eum084
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BIVENTRICULAR PACING
Impacted left ventricular lead technique in cardiac resynchronization therapy
Department of Medicine and Geriatrics, Princess Margaret Hospital, 2-10 Princess Margaret Hospital Road, Lai Chi Kok, Kowloon 852, Hong Kong
Manuscript submitted 31 July 2006. Accepted after revision 9 April 2007.
* Corresponding author. Tel: +852 29901111; fax: +852 29903329. E-mail address: ngaiyinchan{at}yahoo.com.hk
| Abstract |
|---|
|
|
|---|
Left ventricular (LV) lead dislodgement is a significant problem in cardiac resynchronization therapy and re-operation is required to rectify the situation. In this case report, we describe a new technique to stabilize an LV lead which is prone to dislodgement by impacting an inactive LV lead in the same cardiac vein.
Key Words: Pacing, Congestive heart failure
| Introduction |
|---|
|
|
|---|
Despite the advancement in left ventricular (LV) lead delivery system, cardiac resynchronization therapy (CRT) remains a technically challenging procedure. In the MIRACLE study, a failure rate of 7.5% and LV lead reposition or replacement rate of 5.7% were reported.1
| Case report |
|---|
|
|
|---|
A 70-year-old lady with a history of dilated cardiomyopathy, NYHA Class III heart failure despite medical treatment, ECG morphology of left bundle branch abnormality pattern with QRS width of 200 ms and poor LVEF of 20% received CRT. Coronary sinus (CS) venogram revealed a small and tortuous posterolateral cardiac vein (CV) and a sizable lateral CV with a gentle take-off and division into two tributaries distally (Figure 1A). A 6 F guidewire-driven LV lead (Easytrak 3, Guidant Corp., Minneapolis, MN) with a three-dimensional helical shape for stabilization was chosen as the lead of choice for the lateral CV. However, the whole helical part of the LV lead, which has a length of 53 mm, could not be totally positioned inside the lateral CV. A 5.4 F guidewire-driven LV lead (Easytrak 2, Guidant Corp., Minneapolis, MN) was then chosen and passed to the lateral CV distally easily and without significant manipulation. The electrical parameters while pacing at that site were satisfactory. Although the pacing parameters of the posterolateral sub-branch of the lateral CV were optimal, there was diaphragmatic stimulation with pacing at that site. The right atrial (RA) lead was implanted at the RA appendage and the right ventricular (RV) lead was screwed at high RV septum. All the electrical parameters were satisfactory and the leads were then connected to a biventricular pacemaker (Contak Renewel TR, Guidant Corp., Minneapolis, MN). Chest X-ray on Day 2 revealed dislodgement of the LV lead. An attempt to pass a guidewire through the small and tortuous posterolateral CV failed and in view of the fact that there was a high likelihood of recurrent dislodgement with the LV lead in the same CV, a new technique was attempted to insure stability of the LV lead. An electrically active LV lead (Easytrak 2, Guidant Corp., Minneapolis, MN) was re-implanted at the lateral sub-branch of the lateral CV through the CS sheath (Rapido Advance CS-EHR, Guidant Corp., Minneapolis, MN). The CS sheath was removed. A second electrically inactive LV lead (Easytrak 2, Guidant Corp., Minneapolis, MN) was then implanted through a CS sheath (Rapido Advance CS-EHR, Guidant Corp., Minneapolis, MN) at the posterolateral sub-branch of the same lateral CV as an impacted LV lead for stabilizing the electrically active lead (Figure 1B). The electrically active LV lead was connected to the biventricular pacemaker and the electrically inactive LV lead was capped. The pacing threshold was 0.5 V at a pulse width of 0.5 ms with sensing at 30 mV. The position and electrical parameters of the LV lead remained stable at 1 month follow-up.
|
| Discussion |
|---|
|
|
|---|
Although there has been rapid technological advancement in transvenous LV lead delivery systems, procedure failure remains a significant problem and occurred in 7.5% of cases in an early series.1
Conflict of interest: none declared.
| References |
|---|
|
|
|---|
[1] Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 346:1845–53.
[2] Alonso C, Leclercq C, d'Allonnes FR, Pavin D, Victor F, Mabo P, et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart (2001) 86:405–10.
[3] Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 352:1539–49.
[4] Valls-Bertault V, Mansourati J, Gilard M, Etienne Y, Munier S, Blanc JJ. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: early experience from a single centre. Eur J Pacing Electrophysiol (2001) 3:60–3.
[5] Cesario D, Shenoda M, Brar R, Shivkumar K, et al. Left ventricular lead stabilization utilizing a coronary stent. PACE (2006) 29:427–8.[Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
